HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Tylki-Szymańska Selected Research

Fibrosis (Cirrhosis)

1/2020Liver involvement in NGLY1 congenital disorder of deglycosylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Tylki-Szymańska Research Topics

Disease

14Mucopolysaccharidoses
10/2022 - 07/2006
13Gaucher Disease (Gaucher's Disease)
01/2023 - 09/2004
10Mucopolysaccharidosis II (Hunter Syndrome)
02/2022 - 09/2011
9Lysosomal Storage Diseases (Lysosomal Storage Disease)
12/2021 - 01/2011
8Congenital Disorders of Glycosylation
08/2021 - 01/2020
6Fabry Disease (Fabry's Disease)
05/2020 - 11/2009
6Metabolic Diseases (Metabolic Disease)
09/2013 - 02/2008
5Disease Progression
01/2022 - 01/2014
5Inborn Genetic Diseases (Disease, Hereditary)
03/2021 - 01/2011
5Wolman Disease (Wolman's Disease)
01/2021 - 01/2014
5Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy)
06/2015 - 01/2012
4Mucopolysaccharidosis I (Hurler Syndrome)
12/2018 - 08/2007
3Mucopolysaccharidosis IV (Morquio Syndrome)
10/2022 - 05/2019
3Niemann-Pick Diseases (Niemann Pick Disease)
08/2020 - 01/2007
3Hyperkinesis
01/2020 - 01/2020
3Hepatomegaly
10/2018 - 08/2012
2Metachromatic Leukodystrophy (Sulfatide Lipidosis)
02/2021 - 09/2013
2Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
02/2021 - 01/2007
2Failure to Thrive
05/2020 - 01/2014
2Glycogen Storage Disease Type II (Pompe's Disease)
05/2020 - 02/2011
2Sensorineural Hearing Loss
05/2020 - 12/2015
2NGLY1 deficiency
01/2020 - 01/2020
2Developmental Disabilities (Developmental Disability)
01/2020 - 01/2020
2Cholesterol Ester Storage Disease
10/2018 - 01/2014
2Seizures (Absence Seizure)
12/2015 - 05/2012
2Splenomegaly
01/2014 - 08/2012
2Peroxisomal Disorders (Peroxisomal Disorder)
01/2014 - 01/2009
2Acidosis
08/2012 - 05/2012
2Thrombocytopenia (Thrombopenia)
08/2012 - 09/2004
2Lipidoses
01/2011 - 01/2011
1Movement Disorders (Movement Disorder)
01/2023
1Sphingolipidoses (Sphingolipidosis)
01/2023
1Rare Diseases (Rare Disease)
01/2023
1Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
01/2023
1Inborn Errors Metabolism (Inborn Errors of Metabolism)
01/2022
1Arthrogryposis
10/2021
1Ichthyosis (Xeroderma)
10/2021
1Body Weight (Weight, Body)
09/2021
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
09/2021
1Transaldolase Deficiency
08/2021
1End Stage Liver Disease
08/2021
1GM2 Gangliosidoses (GM2 Gangliosidosis)
02/2021
1isovaleric Acidemia
09/2020
1Neonatal-onset citrullinemia type 2
05/2020
1Hypoalbuminemia
05/2020
1Obstructive Jaundice (Cholestatic Jaundice)
05/2020
1Exocrine Pancreatic Insufficiency
05/2020
1Hyperopia (Hypermetropia)
05/2020

Drug/Important Bio-Agent (IBA)

20EnzymesIBA
01/2023 - 03/2002
9GlycosaminoglycansIBA
01/2022 - 07/2006
9LipidsIBA
08/2021 - 01/2007
6Glucosylceramidase (Glucocerebrosidase)IBA
01/2023 - 10/2004
6Proteins (Proteins, Gene)FDA Link
08/2021 - 09/2004
5Transaminases (Aminotransferases)IBA
01/2020 - 01/2014
4Glucosylceramides (Glucocerebrosides)IBA
01/2023 - 12/2011
4idursulfaseFDA Link
02/2022 - 01/2014
4Transferrin (beta 2 Transferrin)IBA
09/2021 - 01/2020
4Triglycerides (Triacylglycerol)IBA
01/2021 - 01/2014
4N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA
06/2015 - 02/2012
3CholesterolIBA
12/2021 - 01/2007
3Protein Isoforms (Isoforms)IBA
03/2021 - 09/2013
3Lysergic Acid Diethylamide (LSD)IBA
02/2021 - 01/2011
3Polysaccharides (Glycans)IBA
01/2021 - 01/2021
3Cholesterol Esters (Cholesteryl Esters)IBA
01/2021 - 01/2014
3Dermatan SulfateIBA
06/2015 - 09/2011
2chitotriosidaseIBA
01/2023 - 01/2018
2GlycosphingolipidsIBA
01/2023 - 01/2007
2Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2021 - 04/2016
2Sebelipase alfaIBA
01/2021 - 10/2018
2Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
08/2020 - 01/2019
2Sterol Esterase (Hormone-Sensitive Lipase)IBA
06/2020 - 01/2014
2sphingosyl beta-glucosideIBA
01/2020 - 01/2018
2Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseIBA
01/2020 - 01/2020
2GalactosidasesIBA
01/2019 - 01/2018
2LDL CholesterolIBA
10/2018 - 01/2014
2HDL CholesterolIBA
10/2018 - 01/2014
2AcidsIBA
12/2015 - 02/2011
2Adenylosuccinate lyase deficiencyIBA
02/2014 - 05/2012
2Fatty Acids (Saturated Fatty Acids)IBA
01/2014 - 01/2009
2IsoflavonesIBA
09/2011 - 07/2006
1alpha-SynucleinIBA
01/2023
1Messenger RNA (mRNA)IBA
01/2023
1IronIBA
01/2023
1Ambroxol (Mucosolvan)IBA
01/2022
1Collodion (Nitrocellulose)IBA
10/2021
1Congenital disorder of glycosylation type 1AIBA
09/2021
1NucleotidesIBA
04/2021
1DolicholsIBA
03/2021
1OligosaccharidesIBA
03/2021
1Glycoproteins (Glycoprotein)IBA
03/2021
1CeroidIBA
02/2021
1Lipase (Acid Lipase)FDA Link
01/2021
1Leucine (L-Leucine)FDA Link
09/2020
1SphingomyelinsIBA
08/2020
1CitrullineIBA
05/2020
1Amino AcidsFDA Link
05/2020

Therapy/Procedure

21Enzyme Replacement Therapy
01/2023 - 10/2004
9Therapeutics
01/2022 - 07/2006
2Liver Transplantation
08/2021 - 01/2020
1Duration of Therapy
05/2020